| RS1722345825 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1722347968 |
RNF13
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1722355988 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1722414362 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1722443590 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS1722451930 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1722452431 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1722457560 |
GFM1
|
Health Risk |
Pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1722463582 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1722491084 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1722635259 |
MME
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2T, MME-related disorder |
| RS17226526 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1722704092 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1722706795 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Ovarian cancer |
| RS1722726229 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1722728402 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1722731535 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS1722734460 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1722736328 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1722737993 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS17227403 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS1722814486 |
EVC2
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1722830922 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Intellectual disability, Chopra-Amiel-Gordon syndrome |
| RS1722845773 |
PROM1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1722855407 |
PROM1
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1722884769 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1722933723 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1722942071 |
EVC2
|
Health Risk |
Likely pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS1722951842 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1722958726 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1722972972 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1722986802 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1723019796 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1723042117 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1723136070 |
ABRAXAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1723295850 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS17232973 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1723365687 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1723367742 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1723387280 |
PPA2
|
Health Risk |
Likely pathogenic |
Sudden cardiac failure, infantile |
| RS1723396043 |
POLR2B
|
Health Risk |
Likely pathogenic |
Esophageal atresia/tracheoesophageal fistula, Esophageal atresia/tracheoesophageal fistula |
| RS1723460138 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1723542820 |
ANKRD17
|
Health Risk |
Likely pathogenic |
Chopra-Amiel-Gordon syndrome, Chopra-Amiel-Gordon syndrome |
| RS1723543163 |
PROM1
|
Health Risk |
Likely pathogenic |
— |
| RS1723551652 |
MED12L
|
Health Risk |
Pathogenic |
Nizon-Isidor syndrome, Nizon-Isidor syndrome |
| RS1723572750 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1723603076 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Idiopathic hypereosinophilic syndrome |
| RS1723605295 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1723609962 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS17236798 |
SLC12A6
|
Health Risk |
Conflicting classifications of pathogenicity |
Agenesis of the corpus callosum with peripheral neuropathy, SLC12A6-related disorder |
| RS1723717935 |
P3H2
|
Health Risk |
Likely pathogenic |
— |
| RS1723731778 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Factor I deficiency, Factor I deficiency |
| RS1723933181 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1723935867 |
CFI
|
Health Risk |
Likely pathogenic |
CFI-related disorder, CFI-related disorder |
| RS1723938282 |
TRMT10A
|
Health Risk |
Likely pathogenic |
Microcephaly, short stature |
| RS1723945036 |
HPS3
|
Health Risk |
Conflicting classifications of pathogenicity |
HPS3-related disorder, HPS3-related disorder |
| RS1723945421 |
NFKB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency, common variable |
| RS1724152035 |
TRMT10A
|
Health Risk |
Pathogenic |
— |
| RS1724246827 |
TRMT10A
|
Health Risk |
Pathogenic |
Microcephaly, short stature |
| RS1724263784 |
MED12L
|
Health Risk |
Likely pathogenic |
Nizon-Isidor syndrome, Nizon-Isidor syndrome |
| RS1724289595 |
PCYT1A
|
Health Risk |
Pathogenic |
Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome, Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome |
| RS1724341846 |
PIK3CA
|
Health Risk |
Pathogenic |
PIK3CA related overgrowth syndrome, PIK3CA related overgrowth syndrome |
| RS1724342112 |
PIK3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
PIK3CA-related disorder, Neoplasm |
| RS1724343994 |
PIK3CA
|
Health Risk |
Likely pathogenic |
PIK3CA related overgrowth syndrome, Overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes |
| RS1724363237 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Squamous cell lung carcinoma, Squamous cell lung carcinoma |
| RS1724367933 |
EXOSC9
|
Health Risk |
Pathogenic |
— |
| RS1724402529 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 13, Atypical hemolytic-uremic syndrome with I factor anomaly |
| RS1724405916 |
PIK3CA
|
Health Risk |
Pathogenic |
Colorectal cancer, Colorectal cancer |
| RS1724417810 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1724507777 |
PIK3CA
|
Health Risk |
Pathogenic |
CLOVES syndrome, Capillary malformation |
| RS1724509208 |
HPS3
|
Health Risk |
Pathogenic |
— |
| RS1724515936 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1724674149 |
PIK3CA
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephaly-capillary malformation-polymicrogyria syndrome, Neoplasm |
| RS1724822643 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic hypereosinophilic syndrome, Gastrointestinal stromal tumor |
| RS1724867456 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1724875502 |
NFKB1
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1724876868 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS1724918747 |
PIK3CA
|
Health Risk |
Conflicting classifications of pathogenicity |
Cowden syndrome, Cowden syndrome |
| RS1724946838 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS1724954436 |
PIK3CA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1725000714 |
NSD2
|
Health Risk |
Pathogenic |
4p partial monosomy syndrome, 4p partial monosomy syndrome |
| RS1725011800 |
BBS7
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome |
| RS1725107158 |
PRDM5
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 2, Brittle cornea syndrome 2 |
| RS1725126993 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1725164851 |
SPRY1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1725177764 |
FRAS1
|
Health Risk |
Pathogenic |
— |
| RS1725178752 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725182255 |
FRAS1
|
Health Risk |
Pathogenic |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1725366621 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS1725368580 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS1725385758 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, BBS7-related disorder |
| RS1725388372 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS1725410386 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725413862 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725424733 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1725442904 |
GFM1
|
Health Risk |
Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1725514012 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS1725516307 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS1725516710 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS1725520104 |
CP
|
Health Risk |
Likely pathogenic |
— |